Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what the cost has been to the NHS of purchasing anti-depressants in each of the last 10 years.
The cost to the National Health Service of antidepressant drugs1 prescribed and dispensed to patients in England is shown in the table.
Year | Primary care net ingredient cost2 £k | Secondary care cost3 £k | Total cost £k |
2005 | 338,546.7 | 16,907.9 | 355,454.6 |
2006 | 291,511.4 | 14,112.4 | 305,623.8 |
2007 | 276,107.6 | 12,496.8 | 288,604.4 |
2008 | 247,355.1 | 11,360.6 | 258,715.7 |
2009 | 230,062.9 | 9,816.0 | 239,878.8 |
2010 | 220,372.8 | 8,223.5 | 228,596.3 |
2011 | 270,177.2 | 7,819.4 | 277,996.6 |
2012 | 211,145.4 | 7,453.6 | 218,599.0 |
2013 | 282,121.6 | 8,708.9 | 290,830.5 |
2014 | 265,003.7 | 8,901.4 | 273,905.1 |
2015 | 284,745.6 | 9,232.8 | 293,978.4 |
Source: Prescription Cost Analysis and Hospital Pharmacy Audit Index © IMS HEALTH 2016 provided by NHS Digital
1 For primary care, antidepressant drugs are defined as those listed in the British National Formulary (BNF) section 4.3 using the classification prior to edition 70. For secondary care, data on all drugs listed in BNF section 4.3 have been extracted from the Hospital Pharmacy Audit Index.
2 Net ingredient cost is the basic cost of a drug. It does not take account of discounts, dispensing costs, fees or prescription charge income.
3 The cost of the medicines at NHS list price and not necessarily the price the hospital paid. May include drugs dispensed via hospital pharmacies to private patients in private wards within NHS hospitals.